These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35449157)

  • 1. USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma.
    Ning Z; Guo X; Liu X; Lu C; Wang A; Wang X; Wang W; Chen H; Qin W; Liu X; Zhou L; Ma C; Du J; Lin Z; Luo H; Otkur W; Qi H; Chen D; Xia T; Liu J; Tan G; Xu G; Piao HL
    Nat Commun; 2022 Apr; 13(1):2187. PubMed ID: 35449157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis.
    Bhalla K; Hwang BJ; Dewi RE; Ou L; Twaddel W; Fang HB; Vafai SB; Vazquez F; Puigserver P; Boros L; Girnun GD
    Cancer Res; 2011 Nov; 71(21):6888-98. PubMed ID: 21914785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IKKβ-USP30-ACLY Axis Controls Lipogenesis and Tumorigenesis.
    Gu L; Zhu Y; Lin X; Lu B; Zhou X; Zhou F; Zhao Q; Prochownik EV; Li Y
    Hepatology; 2021 Jan; 73(1):160-174. PubMed ID: 32221968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmitoyltransferase ZDHHC6 promotes colon tumorigenesis by targeting PPARγ-driven lipid biosynthesis via regulating lipidome metabolic reprogramming.
    Shan J; Li X; Sun R; Yao Y; Sun Y; Kuang Q; Dai X; Sun Y
    J Exp Clin Cancer Res; 2024 Aug; 43(1):227. PubMed ID: 39148124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma.
    Wen X; Ling S; Wu W; Shan Q; Liu P; Wang C; Wei X; Ding W; Teng X; Xu X
    Dig Dis Sci; 2020 Apr; 65(4):1064-1073. PubMed ID: 31587155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
    Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
    J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
    Han Q; Chen CA; Yang W; Liang D; Lv HW; Lv GS; Zong QN; Wang HY
    Hepatobiliary Pancreat Dis Int; 2021 Jun; 20(3):251-261. PubMed ID: 33129711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in genes of the de novo lipogenesis pathway and overall survival of hepatocellular carcinoma patients undergoing transarterial chemoembolization.
    Wu YS; Bao DK; Dai JY; Chen C; Zhang HX; Yang Y; Xing JL; Huang XJ; Wan SG
    Asian Pac J Cancer Prev; 2015; 16(3):1051-6. PubMed ID: 25735330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival.
    Nelson ME; Lahiri S; Chow JD; Byrne FL; Hargett SR; Breen DS; Olzomer EM; Wu LE; Cooney GJ; Turner N; James DE; Slack-Davis JK; Lackner C; Caldwell SH; Hoehn KL
    Nat Commun; 2017 Mar; 8():14689. PubMed ID: 28290443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.
    Ling S; Shan Q; Zhan Q; Ye Q; Liu P; Xu S; He X; Ma J; Xiang J; Jiang G; Wen X; Feng Z; Wu Y; Feng T; Xu L; Chen K; Zhang X; Wei R; Zhang C; Cen B; Xie H; Song P; Liu J; Zheng S; Xu X
    Gut; 2020 Jul; 69(7):1322-1334. PubMed ID: 31776228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipogenesis inhibitors: therapeutic opportunities and challenges.
    Batchuluun B; Pinkosky SL; Steinberg GR
    Nat Rev Drug Discov; 2022 Apr; 21(4):283-305. PubMed ID: 35031766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitination of PPAR-gamma by pVHL inhibits ACLY expression and lipid metabolism, is implicated in tumor progression.
    Noh KH; Kang HM; Yoo W; Min Y; Kim D; Kim M; Wang S; Lim JH; Jung CR
    Metabolism; 2020 Sep; 110():154302. PubMed ID: 32589900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP citrate lyase inhibitor triggers endoplasmic reticulum stress to induce hepatocellular carcinoma cell apoptosis via p-eIF2α/ATF4/CHOP axis.
    Zheng Y; Zhou Q; Zhao C; Li J; Yu Z; Zhu Q
    J Cell Mol Med; 2021 Feb; 25(3):1468-1479. PubMed ID: 33393219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia.
    Morrow MR; Batchuluun B; Wu J; Ahmadi E; Leroux JM; Mohammadi-Shemirani P; Desjardins EM; Wang Z; Tsakiridis EE; Lavoie DCT; Reihani A; Smith BK; Kwiecien JM; Lally JSV; Nero TL; Parker MW; Ask K; Scott JW; Jiang L; Paré G; Pinkosky SL; Steinberg GR
    Cell Metab; 2022 Jun; 34(6):919-936.e8. PubMed ID: 35675800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
    Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
    Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-citrate lyase regulates cellular senescence via an AMPK- and p53-dependent pathway.
    Lee JH; Jang H; Lee SM; Lee JE; Choi J; Kim TW; Cho EJ; Youn HD
    FEBS J; 2015 Jan; 282(2):361-71. PubMed ID: 25367309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated lipid metabolism in hepatocellular carcinoma cancer stem cells.
    Bort A; Sánchez BG; de Miguel I; Mateos-Gómez PA; Diaz-Laviada I
    Mol Biol Rep; 2020 Apr; 47(4):2635-2647. PubMed ID: 32125560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of USP22 and ABCC1 during Sorafenib Treatment of Hepatocellular Carcinoma Contribute to Development of Resistance.
    Chang YS; Su CW; Chen SC; Chen YY; Liang YJ; Wu JC
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpesvirus-associated ubiquitin-specific protease (HAUSP) modulates peroxisome proliferator-activated receptor γ (PPARγ) stability through its deubiquitinating activity.
    Lee KW; Cho JG; Kim CM; Kang AY; Kim M; Ahn BY; Chung SS; Lim KH; Baek KH; Sung JH; Park KS; Park SG
    J Biol Chem; 2013 Nov; 288(46):32886-96. PubMed ID: 24072712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms.
    Zaidi N; Royaux I; Swinnen JV; Smans K
    Mol Cancer Ther; 2012 Sep; 11(9):1925-35. PubMed ID: 22718913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.